Jazz Pharmaceuticals to Participate in the BofA Securities 2022 Global Healthcare Conference
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced its participation in the BofA Securities 2022 Global Healthcare Conference on May 10, 2022, at 12:40 p.m. PT / 3:40 p.m. ET in Las Vegas. An audio webcast will be available on the Investor section of their website, with a replay archived for 30 days. Jazz Pharmaceuticals is dedicated to developing innovative medicines in neuroscience and oncology, serving patients in nearly 75 countries. For more details, visit www.jazzpharmaceuticals.com.
- None.
- None.
DUBLIN, May 3, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the BofA Securities 2022 Global Healthcare Conference on Tuesday, May 10, 2022, at 12:40 p.m. PT / 3:40 p.m. ET / 8:40 p.m. IST in Las Vegas.
An audio webcast of the presentation will be available via the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. A replay of the webcast will be archived on the website for 30 days.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases – often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. Within these therapeutic areas, we are identifying new options for patients by actively exploring small molecules and biologics, and through innovative delivery technologies and cannabinoid science. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. For more information, please visit www.jazzpharmaceuticals.com and follow @JazzPharma on Twitter.
Contacts:
Investors:
Andrea N. Flynn, Ph.D.
Vice President, Head, Investor Relations
Jazz Pharmaceuticals plc
InvestorInfo@jazzpharma.com
Ireland +353 1 634 3211
U.S. +1 650 496 2717
Media:
Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
Ireland +353 1 637 2141
U.S. +1 215 867 4948
View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-the-bofa-securities-2022-global-healthcare-conference-301538662.html
SOURCE Jazz Pharmaceuticals plc
FAQ
When is Jazz Pharmaceuticals participating in the BofA Securities 2022 Global Healthcare Conference?
What time will Jazz Pharmaceuticals present at the conference?
Where is the BofA Securities 2022 Global Healthcare Conference being held?
How can I access the Jazz Pharmaceuticals conference presentation?
How long will the Jazz Pharmaceuticals webcast be available for replay?
